Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 310

1.

Taiwan nutritional consensus on the nutrition management for gastric cancer patients receiving gastrectomy.

Hsu PI, Chuah SK, Lin JT, Huang SW, Lo JC, Rau KM, Chen IS, Hsu HY, Sheu BS, Chang WK, Wu DC.

J Formos Med Assoc. 2019 Dec 16. pii: S0929-6646(19)30013-0. doi: 10.1016/j.jfma.2019.11.014. [Epub ahead of print] Review.

2.

A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue.

Tsai HJ, Tai JJ, Chen LT, Wu MS, Yeh KH, Lin CW, Wang TE, Wang HP, Yu FJ, Liou JM, Hsiao CF, Cheng TY, Yeh HJ, Ko CW, Chen MJ, Lo GH, Hsu PI, Chang CS, Hwang WS, Chuang SS, Lee HW, Shun CT, Chiu CF, Wang WM, Hsieh CY, Liu TW, Lin JT, Kuo SH, Cheng AL.

Haematologica. 2019 Nov 14. pii: haematol.2019.228775. doi: 10.3324/haematol.2019.228775. [Epub ahead of print] No abstract available.

3.

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study.

Hsu WF, Yu SH, Lin JT, Wu JC, Hou MC, Huang YH, Wu CY, Peng CY.

Gastroenterol Res Pract. 2019 Oct 10;2019:1743290. doi: 10.1155/2019/1743290. eCollection 2019.

4.

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.

Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang CY, Hsu YC, Chen MJ, Chen CC, Lee JY, Yang TH, Luo JC, Chen CY, Hsu WF, Chen YN, Wu JY, Lin JT, Lu TP, Chuang EY, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

Lancet Infect Dis. 2019 Oct;19(10):1109-1120. doi: 10.1016/S1473-3099(19)30272-5.

PMID:
31559966
5.

Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, Wu CY.

JAMA Intern Med. 2019 May 1;179(5):633-640. doi: 10.1001/jamainternmed.2018.8342.

PMID:
30882847
6.

Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].

Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY.

J Hepatol. 2019 Mar;70(3):581. doi: 10.1016/j.jhep.2018.12.010. Epub 2019 Jan 8. No abstract available.

PMID:
30635242
7.

Eradicating gastric cancer.

Lin JT, Lee YC.

JGH Open. 2017 Dec 19;1(4):124-126. doi: 10.1002/jgh3.12028. eCollection 2017 Dec. No abstract available.

8.

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.

Hsu YC, Nguyen MH, Mo LR, Wu MS, Yang TH, Chen CC, Tseng CH, Tai CM, Wu CY, Lin JT, Tanaka Y, Chang CY.

Aliment Pharmacol Ther. 2019 Jan;49(1):107-115. doi: 10.1111/apt.15058. Epub 2018 Nov 19.

PMID:
30450681
9.

Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice.

Lai ZL, Tseng CH, Ho HJ, Cheung CKY, Lin JY, Chen YJ, Cheng FC, Hsu YC, Lin JT, El-Omar EM, Wu CY.

Sci Rep. 2018 Oct 23;8(1):15625. doi: 10.1038/s41598-018-33893-y.

10.

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.

Hsu YC, Jun T, Huang YT, Yeh ML, Lee CL, Ogawa S, Cho SH, Lin JT, Yu ML, Nguyen MH, Tanaka Y.

Aliment Pharmacol Ther. 2018 Nov;48(10):1128-1137. doi: 10.1111/apt.15006. Epub 2018 Oct 10.

PMID:
30306612
11.

Toward population specific and personalized treatment of Helicobacter pylori infection.

Liou JM, Chen PY, Kuo YT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

J Biomed Sci. 2018 Oct 2;25(1):70. doi: 10.1186/s12929-018-0471-z. Review.

12.

Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.

Chen MJ, Chen CC, Chen YN, Chen CC, Fang YJ, Lin JT, Wu MS, Liou JM; Taiwan Gastrointestinal Disease Helicobacter Consortium.

Am J Gastroenterol. 2018 Oct;113(10):1444-1457. doi: 10.1038/s41395-018-0217-2. Epub 2018 Aug 31.

PMID:
30171216
13.

Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.

Yeo YH, Hsu CC, Lee CC, Ho HJ, Lin JT, Wu MS, Liou JM, Wu CY; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

J Gastroenterol Hepatol. 2019 Jan;34(1):59-67. doi: 10.1111/jgh.14462. Epub 2018 Oct 11.

PMID:
30169908
14.

The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus.

Cheng HC, Liou JM, Luo JC, Chiu CT, Wu MS, Lee YC, Wu CY, Wu DC, Hsu PI, Chang CC, Chang WL, Lin JT, Sheu BS.

Helicobacter. 2018 Oct;23(5):e12533. doi: 10.1111/hel.12533. Epub 2018 Aug 29.

PMID:
30159952
15.

Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients.

Tseng CH, Chang CY, Mo LR, Lin JT, Tai CM, Perng DS, Lin CW, Hsu YC.

Ann Hepatol. 2018 Aug 24;17(5):789-794. doi: 10.5604/01.3001.0012.3137.

16.

The in vivo tissue effect of endoscopic balloon-based radiofrequency ablation in treating esophageal squamous cell neoplasia.

Wang WL, Chang IW, Chen CC, Chang CY, Tseng CH, Tai CM, Lin JT, Wang HP, Lee CT.

United European Gastroenterol J. 2018 Jun;6(5):656-661. doi: 10.1177/2050640618755236. Epub 2018 Feb 2.

17.

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.

Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, Yang TH, Chang CY, Bair MJ, Chen MJ, Hsu YC, Hsu WF, Chang CC, Lin JT, Shun CT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

Gastroenterology. 2018 Oct;155(4):1109-1119. doi: 10.1053/j.gastro.2018.06.047. Epub 2018 Jun 30.

PMID:
29964036
18.

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial.

Liou JM, Chen CC, Fang YJ, Chen PY, Chang CY, Chou CK, Chen MJ, Tseng CH, Lee JY, Yang TH, Chiu MC, Yu JJ, Kuo CC, Luo JC, Hsu WF, Hu WH, Tsai MH, Lin JT, Shun CT, Twu G, Lee YC, Bair MJ, Wu MS; Members of the Taiwan Gastrointestinal Disease and Helicobacter Consortium.

J Antimicrob Chemother. 2018 Sep 1;73(9):2510-2518. doi: 10.1093/jac/dky183.

PMID:
29846605
19.

Low accuracy of chromogranin A for diagnosing early-stage pancreatic neuroendocrine tumors.

Tseng CM, Cheng TY, Chen TB, Tien YW, Chen CC, Lin JT, Wang HP.

Oncol Lett. 2018 Jun;15(6):8951-8958. doi: 10.3892/ol.2018.8472. Epub 2018 Apr 12.

20.

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY.

J Hepatol. 2018 Aug;69(2):278-285. doi: 10.1016/j.jhep.2018.02.032. Epub 2018 Mar 16. Erratum in: J Hepatol. 2019 Mar;70(3):581.

PMID:
29551708

Supplemental Content

Loading ...
Support Center